{"id":"W3174841530","doi":"10.1038/s41416-021-01415-9","title":"Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Breast cancer; Medicine; Oncology; Hormone receptor; Cancer; Internal medicine; Oestrogen receptor; Clinical trial; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003990642,0.0007911677,0.002537625,0.00035538,0.0002927537,0.001069232,0.000721678,0.001654257,0.007720426],"category_scores_gemma":[0.006796573,0.0004123046,0.003177018,0.0003659253,0.0009231889,0.001180052,0.0005082832,0.003795283,0.0008678607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008152071,"about_ca_system_score_gemma":0.000578862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007590583,"about_ca_topic_score_gemma":0.001976889,"domain_scores_codex":[0.9967723,0.00240251,0.0001543074,0.0002097031,0.0001828724,0.0002781995],"domain_scores_gemma":[0.9970226,0.001746379,0.0004768989,0.0002981315,0.0001551564,0.0003010178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9602513,0.0009309807,0.0008466549,0.0006405567,0.002194792,0.00003436547,0.00007498654,0.0009284051,0.001944815,0.0003597333,0.0008862237,0.03090717],"study_design_scores_gemma":[0.8343752,0.1317481,0.01880819,0.0003340079,0.003899115,0.0001612311,0.0001275224,0.001626606,0.001529027,0.002170212,0.005130408,0.00009047904],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652604,0.02252426,0.0007657039,0.002042924,0.0007761075,0.0007264238,0.001328293,0.0001015948,0.006474304],"genre_scores_gemma":[0.9922951,0.002280418,0.0004660746,0.0008619856,0.0002947819,0.0004879688,0.0006864076,0.00003815087,0.002589075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007720426,"threshold_uncertainty_score":0.02582747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01697719221813876,"score_gpt":0.3431304860266393,"score_spread":0.3261532938085006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}